Gestational diabetes & diabetes in pregnancy

Association of gestational thyroid function and thyroid autoimmunity with gestational diabetes: a systematic review and individual participant meta-analysis

Lancet Diabetes EndocrinolPublished Systematic review and individual participant data meta-analysis of prospective population-based cohort studies

Pooled result · GDMResult — go to the resultAdjusted odds ratio 1.52 95% CI 1.17–1.98

Authors' conclusion

A lower FT4 concentration and isolated hypothyroxinaemia during pregnancy are associated with a higher risk of gestational diabetes. Our results challenge the long-standing notion that subclinical hypothyroidism or thyroid autoimmunity are risk factors for gestational diabetes and support both the risk profile for gestational thyroid dysfunction and ongoing efforts on optimisation of treatment targets for pregnant people taking levothyroxine. Follow-up studies are required to establish to what extent levothyroxine initiation or dose adjustments can affect insulin resistance and antihyperglycaemic therapies during pregnancy.

Study context

Population
Pregnant participants of prospective population-based cohorts, excluding multiple pregnancies, pre-existing thyroid disease or DM, medications affecting thyroid or glucose levels, infertility treatment, miscarriage or stillbirth
Participants
63,548 participants25 cohorts
Comparison
Gestational thyroid function and autoimmunity vs euthyroidism
  • Isolated hypothyroxinaemian = 1,113
  • Euthyroidismn = 44,787reference
Outcome
Presence of GDM as defined in individual cohorts
Methodological detailspreregistered protocol, generalised linear mixed-effects regression, adjusted for maternal age, BMI, smoking, parity, ethnicity, fetal sex, gestational age at blood sampling, 638 published studies identified; 21 studies based on 17 cohorts met inclusion criteria; 11 provided individual participant data, 14 cohorts added via personal contacts and open invitations
  • Preregistered protocol
  • Generalised linear mixed-effects regression
  • Adjusted for maternal age, BMI, smoking, parity, ethnicity, fetal sex, gestational age at blood sampling
  • 638 published studies identified; 21 studies based on 17 cohorts met inclusion criteria; 11 provided individual participant data, 14 cohorts added via personal contacts and open invitations

Pooled result

GDM

Adjusted odds ratio

1.52

95% CI 1.17–1.98

P = 0.0017

Events by group

Isolated hypothyroxinaemiavs Euthyroidism
aOR 1.52 (95% CI 1.17–1.98); P = 0.0017

As reported in the abstract

Lower free T4 (FT4) associated with higher GDM risk (non-linear)
P < 0.0001
Higher free T3 (FT3) associated with higher GDM risk, aOR
1.18 (95%CI 1.10-1.28), p<0.0001
Higher FT3-to-FT4 ratio associated with higher GDM risk (non-linear)
P < 0.0001

Further pooled results

I2 for primary analyses (low to moderate heterogeneity)
0-43%
Funnel plot for overt hyperthyroidism indicated possible publication bias
P = 0.049

Original publication

Association of gestational thyroid function and thyroid autoimmunity with gestational diabetes: a systematic review and individual participant meta-analysis. Lancet Diabetes Endocrinol. Published 30 June 2025. doi:10.1016/s2213-8587(25)00068-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.